Illumina CEO: On the path to $100 genome

CNBC's Meg Tirrell talks to Illumina CEO Francis deSouza about lowering the price of genome sequencing and the opportunity it opens up for advancements in medical research.
03:08
Tue, Jan 10 20178:39 AM EST